USDM, DocuSign to Help Life Sciences Organizations Go Fully Digital
News Jun 23, 2014
DocuSign, Inc. and USDM Life Sciences announced a new partnership to help organizations automate regulated business processes for dramatic ROI, increased security and compliance, and faster speed to market. DocuSign offers the industry’s only 21 CFR Part 11 compliant Digital Transaction Management (DTM) platform for easily, safely and securely managing transactions in the cloud, including clinical trials, electronic batch records, regulatory filings, training, change control, field service reports, recall notifications, laboratory procedures and more.
“USDM is pleased to have partnered with DocuSign as the global standard for Digital Transaction Management to expand our Validation Accelerator Pack (VAP) and Cloud Assurance solution,” says Kim Hutchings, Vice President of Alliances at USDM Life Sciences. “Our joint solution brings together USDM’s 10 plus years of VAP experience in the cloud with the power of DocuSign’s DM platform so our customers have an easy to implement, easy to validate solution that accelerates speed to market while meeting critical 21 CFR Part 11 requirements.”
With DocuSign, life science companies can easily, safely and securely manage regulated business processes including clinical trials, electronic batch records, regulatory filings, training, change control, field service reports, recall notifications, and laboratory procedures.
“Our partnership with USDM gives life sciences organizations further confidence to go fully digital with DocuSign as the catalyst for their digital transformation,” said Neil Hudspith, chief revenue officer, DocuSign. “Now life sciences companies can manage all aspects of GxP regulated business processes in the cloud with DocuSign to eliminate paper to accelerate approval times, reduce errors and cut costs to bring critical research and treatments to market faster.”
DocuSign delivers transaction security and compliance for organizations of all sizes, in a wide-ranging number of use cases, with an end-to-end digital solution that is changing the way life sciences companies do business. USDM’s integrated solution with DocuSign includes:
• Validation Accelerator Pack (VAP) / Qualification Package
• Vendor Audit (updated annually)
• Validation Maintenance Package (updated as changes are made with new releases)
• Test automation options
• Subscription based services, providing the ability to maintain compliance
To learn more about USDM please visit http://www.usdm.com/
Big Data Study Targets Genomic Dark Matter from Ocean Floor to Gut FloraNews
An international team led by computational biologist Fran Supek at IRB Barcelona develop a machine learning method to predict unknown gene functions of microbes.The system examines and compares ‘big data’ available on the metagenomes of human and environmental microbiomes.READ MORE
Machine Learning Model Provides Early Dementia DiagnosisNews
Improving dementia care through increased and timely diagnosis is an NHS priority, yet around half of those living with dementia live with the condition unaware. Now a new machine-learning model that scans routinely collected NHS data has shown promising signs of being able to predict undiagnosed dementia in primary care.
ExPecto Patronum! Magical Machine Learning Tool Summons DNA Dark Matter DataNews
A new machine learning framework, dubbed ExPecto, can predict the effects of mutations in the so-called “dark matter” regions of the human genome. ExPecto pinpoints how mutations can disrupt the way genes turn on and off throughout your body.